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Abstract: Malignant melanoma is one of the most aggressive types of skin cancer with an increasing
incidence worldwide. Thus, the development of innovative therapeutic approaches is of great
importance. Salvia fruticosa (SF) is known for its anticancer properties and in this context, we
aimed to investigate its potential anti-melanoma activity in an in vitro model of human malignant
melanoma. Cytotoxicity was assessed through a colorimetric-based sulforhodamine-B (SRB) assay in
primary malignant melanoma (A375), non-malignant melanoma epidermoid carcinoma (A431) and
non-tumorigenic melanocyte neighbouring keratinocyte (HaCaT) cells. Among eight (8) different
fractions of S. fruticosa extracts (SF1-SF8) tested, SF3 was found to possess significant cytotoxic activity
against A375 cells, while A431 and HaCaT cells remained relatively resistant or exerted no cytotoxicity,
respectively. In addition, the total phenolic (Folin–Ciocalteu assay) and total flavonoid content of
SF extracts was estimated, whereas the antioxidant capacity was measured via the inhibition of
tert-butyl hydroperoxide-induced lipid peroxidation and protein oxidation levels. Finally, apoptotic
cell death was assessed by utilizing a commercially available kit for the activation of caspases - 3, - 8
and - 9. In conclusion, the anti-melanoma properties of SF3 involve the induction of both extrinsic
and intrinsic apoptotic pathway(s), as evidenced by the increased activity levels of caspases - 8, and
- 9, respectively.
Keywords: Salvia fruticosa; melanoma; oxidative stress; flavonoids; phenolics; apoptosis
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1. Introduction
Skin cancer is one of the most frequent types of cancer, with increasing rates of
incidence and mortality worldwide [1–4]. One of the most aggressive and deadly forms
of skin cancer is malignant melanoma (MM) as it accounts for approximately 80% of all
types of skin cancer-related deaths [1,3,5,6]. Current therapeutic schemes include surgical
excision (in early stages), as well as chemotherapy, immunotherapy and targeted therapy
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(in advanced and metastatic stages). However, mortality rates remain high despite the
development and improvement of therapeutic approaches. To this end, chemoprevention,
utilizing synthetic and/or naturally derived agents, has emerged as a promising and
alternative approach against cancer management, including MM [7–9].
Salvia species belong to the Lamiaceae family, which consists of 180 genera and approximately 3500 species [10,11]. S. fruticosa (SF) is an endemic plant mainly found in
the Mediterranean and Irano-Turanian regions. It is also known as Greek sage, and has
been reported to exert significant antioxidant and anticancer activity, possibly due to the
presence of phenolic compounds (e.g., Rosmarinic acid; RA) that are well known for their
antioxidant and antitumor effects [11–14]. In melanoma, RA was found to regulate different
signalling pathways, including PKA/CREB/MITF, while also acts as a free radical scavenger and detoxification enzyme modifier [13,15]. Carnosic acid (CA) is another important
diterpene phenolic compound, found in S. fruticosa, also known for its antioxidant and
anti-inflammatory properties. Specifically, the treatment of melanoma cell lines with CA
resulted in: (i) induction of apoptotic cell death; (ii) inhibition of epithelial-to-mesenchymal
transition (EMT) and metastasis; as well as (iii) improvement of the cytotoxicity profile of
several anticancer drugs [16,17].
Previous in vitro studies, conducted in a variety of cancer cell lines, revealed the
beneficial effects of S. fruticosa extracts. For instance, Xavier et al. (2009) reported an
anti-proliferative and pro-apoptotic activity of S. fruticosa in HCT-15 colorectal cancer cells
while its anticancer activity was mediated through the inhibition of the Kirsten rat sarcoma
virus (KRAS) gene and the reduction in reactive oxygen species (ROS) generation levels [12].
Similarly, a study conducted by Altay et al. (2017) indicated the anti-proliferative effect of
S. fruticosa in HT-29 colorectal cancer cells primarily through its antioxidant capacity [15].
Moreover, S. fruticosa extracts were reported to possess significant anti-proliferative activity
against melanoma cells, an effect associated with the G2/M phase of cell cycle growth
arrest [16]. Finally, among the health-beneficial effects of S. fruticosa is its neuroprotective
capacity against the formation of amyloid-beta plaques and subsequently, its protective
potential against neurodegenerative diseases such as Alzheimer’s disease. Such activity
was mainly attributed to its high content of antioxidant compounds including flavonoids,
phenolics and terpenoids. Overall, the above data indicate that S. fruticosa plants contain
promising phytochemicals, with notable biological activity and health-promoting capacity
against a wide range of human diseases including cancer [18].
The purpose of the present study was to characterize the anticancer activity of different S. fruticosa extracts in an in vitro model of human MM consisting of primary malignant melanoma (A375), non-malignant melanoma epidermoid carcinoma (A431) and
non-tumorigenic melanocyte-neighbouring keratinocyte (HaCaT) cells. This in vitro model
allowed us to determine the cytotoxicity and safety profile of S. fruticosa between melanoma
(A375) and non-melanoma (A431) carcinoma, as well as between tumorigenic (A375 and
A431) and non-tumorigenic (HaCaT) cell lines, respectively. Such attempts can be of utmost
importance in developing anticancer strategies for the clinical management of MM.
2. Results
2.1. S. fruticosa Extracts Induce Cytotoxicity in A375 Cells
The cytotoxic capacity of S. fruticosa in A375 cells was evaluated, using the SRB assay,
under increasing concentrations (0.05 mg/mL, 0.1 mg/mL, 0.25 mg/mL, 0.5 mg/mL and
1 mg/mL) of all extracts at 24 and 48 h of exposure. According to our data, all extracts
exhibited a time-dependent reduction in cell viability (Figure 1), to a variable extent, as
evidenced by their respective EC50 values (Table 1). Specifically, the SF4, SF7 and SF8
extract fractions induced a gradual decrease in cell viability (at both time points) followed
by a sharp decline at 1 mg/mL concentration. Their corresponding EC50 values were 0.22,
0.56 and 0.88 mg/mL respectively. However, the SF1, SF5 and SF6 extract fractions were
also shown to gradually decrease cell viability, at both time points, in all concentrations
up to 0.5 mg/mL, followed by a marked increase (at 1 mg/mL) in cell viability values.
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Figure 1.
1. Cytotoxicity
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cells. Cells
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(C)
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(F)
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(G)
SF8
for
24
and
48
h. Data
0.05–1 mg/mL concentrations of (A) SF1, (B) SF3, (C) SF4, (D) SF5, (E) SF6, (F) SF7 and (G) SF8 for 24 and 48 h. Data
were
were expressed as mean values ± SD of 5 replicates from three independent experiments. Asterisk (*) denotes statistical
significance when compared to their respective DMSO (0.1%) control at p < 0.05. ** and ## denote statistical significance at
p < 0.01, whereas *** and ### denote statistical significance at p < 0.001.

Plants 2021, 10, 2472

4 of 14
Plants 2021, 10, x FOR PEER REVIEW

4 of

Table 1. Half maximal effective concentrations (EC50 ) of various S. fruticosa extract fractions (SFs)
cells,
post-exposure.
expressedagainst
as meanA375
values
± SDatof485 hreplicates
from three independent experiments. Asterisk (*) denotes statistical significance when compared to their respective DMSO (0.1%) control at p < 0.05. ** and ## denote statistical significance at p <
###denote statistical significance
Fraction
Extraction at
Solvent
EC50 (mg/mL) (48 h)
p < 0.001.
0.01, whereas *** and
SF1
SF3
SF4
SF5
SF6
SF7
SF8

Petroleum ether
0.82
S. fruticosa extract fractions (SFs
Table 1. Half maximal
effective concentrations (EC50) of various
Methanol
0.048
against A375 cells, at 48
h post-exposure.
Water
0.22
Diethyl ether

0.57

Fraction
Extraction Solvent
EC50 (mg/mL) (48 h)
Ethyl acetate
0.17
SF1
0.82
n-Butanol Petroleum ether
0.56
SF3
Methanol
0.048
Water
0.88
SF4
Water
0.22
SF5
Diethyl ether
0.57
Finally, it is worth mentioning that although we had collected an SF2 extract fraction
SF6
acetate
0.17
(by using dichloromethane as an extraction Ethyl
solvent),
it was not possible to screen
it in
SF7found to be poorly soluble
n-Butanol
0.56
our MM model as it was
in either water or dimethyl sulfoxide
SF8
Water of insoluble crystals.
0.88
(DMSO) or methanol (MeOH),
due to the precipitation

2.2. The
Methanolic
(SF3) No
Exerts
Either No or
Cytotoxicity
a Minimal
One in
2.2. The Methanolic
Extract
FractionExtract
(SF3) Fraction
Exerts Either
Cytotoxicity
a MinimalorOne
in
and
HaCaT Cells, Respectively
A431 and HaCaTA431
Cells,
Respectively
In the
next series of we
experiments,
examined
observed SF3-induc
In the next series
of experiments,
examinedwe
whether
the whether
observedthe
SF3-induced
cytotoxicity
was
specific
A375
cells byautilizing
a colorimetric
SRB To
assay.
cytotoxicity was
specific to
A375
cellstoby
utilizing
colorimetric
SRB assay.
do To
so,do so, no
(A431)
and non-malignant
keratinocyte
cellstreated
were treated
non-melanomamelanoma
(A431) and
non-malignant
keratinocyte
(HaCaT)(HaCaT)
cells were
with with 0.
h. The
results that
revealed
that cell was
viability
was not affected
0.05 mg/mL of mg/mL
SF3 for of
24SF3
andfor
48 24
h. and
The 48
results
revealed
cell viability
not affected
HaCaT-treated
cells,
at
both
time
points
of
exposure,
while,
although
in c
in HaCaT-treated cells, at both time points of exposure, while, although a reductionainreduction
cell
viability
was
observed
in
A431-treated
cells,
it
was
to
a
lesser
extent
when
compared
viability was observed in A431-treated cells, it was to a lesser extent when compared to
A375our
cells.
Overall,
ourthe
data
support
the
notion
are less
resistant
to the cytotox
A375 cells. Overall,
data
support
notion
that
A375
arethat
lessA375
resistant
to the
cytotoxic
effect
of
the
methanolic
extract
fraction
(SF3)
when
compared
to
A431
and
HaCaT cel
effect of the methanolic extract fraction (SF3) when compared to A431 and HaCaT cells,
thereby
indicating
a
melanoma-specific
anticancer
ability
of
this
particular
extract
fracti
thereby indicating a melanoma-specific anticancer ability of this particular extract fraction
of
S.
fruticosa
(Figure
2).
of S. fruticosa (Figure 2).

Figure 2. Cytotoxicity
of theextract
methanolic
in HaCaT
and
A431and
cells.
Figure 2. Cytotoxicity
effect of the effect
methanolic
fractionextract
(SF3) infraction
HaCaT (SF3)
and A431
cells. (A)
HaCaT
(B) A431
cells were(A)
exposed
to SF3
a concentration
of 0.05
mg/mL,
48 h. Data were
as mean
values
HaCaT
andat(B)
A431 cells were
exposed
to for
SF324atand
a concentration
ofexpressed
0.05 mg/mL,
for 24
and± SD of
5 replicates
three
independent
Asterisks
a statistical
significance experiments.
at p < 0.001 relative
48from
h. Data
were
expressedexperiments.
as mean values
± SD(***)
of 5demonstrate
replicates from
three independent
to corresponding DMSO (0.1%) control.
Asterisks (***) demonstrate a statistical significance at p < 0.001 relative to corresponding DMSO
(0.1%) control.

2.3. The Methanolic Extract Fraction (SF3) Is a Rich Source of Phenolic and Flavonoid
Compounds
2.3. The Methanolic
Extract Fraction (SF3) Is a Rich Source of Phenolic and Flavonoid Compounds
Next,
we sought the
to determine
the total
andcontents
flavonoid
contents
Next, we sought
to determine
total phenolic
andphenolic
flavonoid
(TPC
and (TPC a
TFC,
of extract
all S. fruticosa
extract
attemptthe
to identify
the ones wi
TFC, respectively)
ofrespectively)
all S. fruticosa
fractions
in anfractions
attemptintoanidentify
ones with
major
potential
antioxidant
capacity.
Our
results
indicated
that
SF3
was
the
richest
extra
major potential antioxidant capacity. Our results indicated that SF3 was the richest extract

fraction in the context of having the highest TPC (319.188 µg of GAE/g of extract) and TFC

Plants 2021, 10, x FOR PEER REVIEW

5 of 14

fraction in the context of having the highest TPC (319.188 μg of GAE/g of extract) and5 TFC
of 14
(1054.66 μg of RE/g extract and 664.574 μg of CE/g extract) compared to the other fractions. On the contrary, the lowest TPC was observed in the SF8 fraction (46.38 μg of GAE/g
of extract),
theextract
lowestand
TFC664.574
was recorded
in the
SF2, SF5,
and SF7
2).
(1054.66
µg while
of RE/g
µg of CE/g
extract)
compared
to fractions
the other (Table
fractions.
On the contrary, the lowest TPC was observed in the SF8 fraction (46.38 µg of GAE/g of
Table 2. Determination of total
phenolic
andthe
flavonoid
in recorded
various extract
of S.
fruticosa.
Data shown
are 2).
extract),
while
lowestcontents
TFC was
in thefractions
SF2, SF5,
and
SF7 fractions
(Table

Plants 2021, 10, 2472

mean values ± SD of at least three independent experiments.
Table 2. Determination of total phenolic and flavonoid contents in various extract fractions of S. fruticosa. Data shown are
SF1
SF2
SF3
SF4
SF5
SF6
SF7
SF8
mean values ± SD of at least three independent experiments.
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3. Discussion
Melanoma is one of the most aggressive types of cancers with extremely low survival
Melanoma is one of the most aggressive types of cancers with extremely low survival
rates [19–23]. Previous studies have shown a beneficial effect of S. fruticosa against human
rates [19–23]. Previous studies have shown a beneficial effect of S. fruticosa against human
breast and colorectal cancers [10,12,15,24,25]. Taken together, in the current study, we
breast and colorectal cancers [10,12,15,24,25]. Taken together, in the current study, we
aimed to characterize the anticancer potential of various fractions of S. fruticosa extracts
aimed to characterize the anticancer potential of various fractions of S. fruticosa extracts
against malignant melanoma. To this end, we used seven (e.g., SF1, SF3, SF4, SF5, SF6, SF7
against malignant melanoma. To this end, we used seven (e.g., SF1, SF3, SF4, SF5, SF6, SF7
and SF8) S. fruticosa extract fractions obtained using different extraction solvents: petroand SF8) S. fruticosa extract fractions obtained using different extraction solvents: petroleum
leum ether, dichloromethane, methanol, diethyl ether, ethyl acetate, n-butanol and water.
ether, dichloromethane, methanol, diethyl ether, ethyl acetate, n-butanol and water. The
The
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the polarity
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the differences
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of each
of theofsolvents
utilized
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observed
in the TPC, TFC and overall cytotoxicity profile data. In order to examine the cytotoxic
effects of S. fruticosa extracts in melanoma, A375 cells were treated with these seven extract
fractions under increasing concentrations ranging from 0.05 to 1 mg/mL. Interestingly,
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our results indicated that among all tested extract fractions, SF3 was the most potent in
reducing cell viability levels of A375 cells. The corresponding EC50 value was calculated to
be 0.048 mg/mL at 48 h post-exposure, and thus, was shown to be significantly lower when
compared to the rest of the tested extracts. On the contrary, the SF1 and SF8 extract fractions
were the least effective with corresponding EC50 values calculated to be 0.82 mg/mL and
0.88 mg/mL, respectively. In other words, they required 17–18-fold higher concentrations
to reduce A375 cell viability to 50% when compared to SF3. Hence, SF3 was selected as the
most cytotoxic extract for all subsequent experimental designs. Moreover, in another set
of experiments, we aimed to examine the specificity of SF3-induced cytotoxicity, towards
A375 cells only, by subjecting non-melanoma epidermoid carcinoma (A431) cells to the
action of SF3. We showed that A431 cells were significantly more resistant to the cytotoxic
action of this methanolic extract fraction, thereby suggesting a specific effect of SF3 in
malignant melanoma cells. Obviously, this is largely speculation at this stage, and more
elaborate experiments are needed in order to prove our initial hypothesis. Finally, we tested
the cytotoxic effect of SF3 in non-malignant immortalized keratinocyte (HaCaT) cells on the
basis that since they neighbour melanocytes, they could account for the determination of
any cytotoxic side effects as a consequence of SF3’s action. In fact, when HaCaT cells were
subjected to 0.048 mg/mL, over 48 h, no cytotoxicity was observed, thereby suggesting
a safe profile of SF3 usage under these experimental conditions. In a relatively similar
study, Koutsoulas et al. (2019) tested the methanolic extract fractions of S. fruticosa and
S. pomifera, as well as carnosic acid itself in human melanoma (A375) and (Mel JuSo) cell
lines. Their results revealed increased cytotoxicity on both cell lines with an IC50 value of
0.058 mg/mL in A375 cells [16]. Obviously, our results are in agreement with the finding
of this study, as we reported an EC50 value of 0.048 mg/mL (compared to 0.058 mg/mL)
for the methanolic extract fraction of S. fruticosa in A375 cells. Similar results have also
been supported by other in vitro studies exploiting the cytotoxic effects of S. fruticosa in
other forms of cancers (e.g., breast and colorectal), thereby proposing significant anticancer
activity. For instance, in a study by Tundis et al. (2017), it was reported that the exposure of
breast (MCF-7 and MB-231) and colorectal (Caco-2 and RKO) cancer cell lines to different
concentrations of S. fruticosa resulted in a time- and concentration-dependent reduction
in the viability levels of these cells [24]. Specifically, it was suggested that the cytotoxic
effects of S. fruticosa are mainly attributed to the presence of carnosic acid [16], a strong
antioxidant diterpene phenolic compound, with significant anti-neoplastic capacity against
a variety of cancers including leukaemia, colorectal, brain and liver [16,26–29]. This, in turn,
supports the notion of a synergistic effect between carnosic acid with other compounds
such as phenols, flavonoids, pigments, sugars, etc., all of which are potentially present in
the methanolic extract fraction of S. fruticosa and, thus, may contribute collectively to the
observed anticancer capacity of this species.
On another note, ROS are capable of attacking biological macromolecules such as
lipids, proteins and DNA, thus resulting in the generation of lipid peroxidation, protein
carbonylation and DNA oxidation by-products, all of which can ultimately lead to mutagenesis. For this reason, the presence of both enzymatic (e.g., Superoxide Dismutase
(SOD), Glutathione Peroxidase (GPx), Catalase (CAT), etc.) and non-enzymatic antioxidants (e.g., ascorbic acid (vitamin C), α-tocopherol (vitamin E), glutathione (GSH), etc.),
ensure the metabolism and elimination of excess ROS production [30–33]. However, when
an imbalance between ROS production and anti-oxidant defence system occurs, it favours
the accumulation of ROS, an unfavourable condition called oxidative stress that is closely
related to carcinogenesis [34–37]. To these ends, increased ROS formation is highly associated with melanoma development, metabolism, immune response, melanin biosynthesis
and metastasis [32,37–39]. Consequently, this suggests that naturally-derived phytochemicals, rich in antioxidant compounds, could potentially restore the imbalance favouring
ROS generation back to a “physiological/redox state” by increasing the cellular metabolic
activity of ROS and, thus, potentially inhibiting melanoma progression [30–32]. For instance, several studies have indicated the antioxidant capacity of various Salvia species,
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including S. fruticosa, attributed mostly to their phenolic and/or flavonoid compounds’
content [11,15,24,26,30,40,41], which can either donate hydroxyl groups to ROS and/or
reactive nitrogen species (RNS) and/or chelate free metal ions that contribute to ROS formation and prevent their accumulation and, consequently, their detrimental effects [42–44].
Several studies conducted in melanoma and other skin cancers have revealed the significance of phenolic compounds as potential anticancer agents against both aggressive and
non-aggressive types of skin cancer. For instance, cinnamic acid, a known phenolic compound, is capable of exerting a cytotoxic effect of HT-44 melanoma cells, while ferulic and
caffeic acids were found to inhibit melanoma cell proliferation through down-regulation
of PI3K/Akt signalling pathways [45–48]. Furthermore, a study published by Melo et al.
(2018) utilizing phenolic compounds extracted from Viscum album tinctures, showed morphological changes and reduction in cell viability in B16F10 murine melanoma cell lines
together with apoptotic activation [49]. In this context, in the present study, we measured
the total phenolic and flavonoid contents of seven S. fruticosa extract fractions in order
to investigate whether their observed cytotoxicity profiles are linked to the contents of
these antioxidant compounds [30,50–55]. A high yield of total flavonoids and phenolics
was expected in S. fruticosa extracts, as it has been already reported in previous studies [12,16,56,57]. Nonetheless, there was a discrepancy in the content between each of the
tested extract fractions. More specifically, according to Ververis et al. (2020), the method
of extraction (e.g., polar versus semi-polar versus non-polar extraction solvents) strongly
affects the amount of total phenolic and flavonoid contents and subsequently affects the
impact that each fraction has on cells [18]. As expected, in our study, the methanolic extract
fraction (SF3) had the highest content on both phenolics and flavonoids, followed by SF4
and SF6, while the lowest content was observed in SF8 (for total phenolics) and in SF2
and SF7 (for total flavonoids). Furthermore, the antioxidant capacity of S. fruticosa was
also evaluated through measuring its potential to inhibit protein carbonylation and lipid
peroxidation contents. More specifically, increased intracellular ROS levels may result
in direct damage of a protein’s amino acids and/or peroxidation of the lipid bilayer of
cellular membranes, thus potentially leading to conformational changes associated with
several diseases [58–60]. In this context, following incubations of A375 cells with TBH
(a ROS-inducing agent), it was shown that both malondialdehyde (a lipid peroxidation
marker) and carbonyl content (a protein oxidation marker) levels were significantly increased, as expected [61–64]. However, incubation of these cells with SF3 significantly
reduced intracellular lipid and protein oxidation levels to a variable degree with a more
notable degree of reduction regarding protein carbonyl content.
Finally, in an attempt to further delineate the modes of the observed SF3-induced cytotoxicity, we employed a multiplex assay activity kit for caspases - 3, - 8 and - 9. According to
our data, all three caspases were activated to a variable degree, suggesting the involvement
of apoptotic induction as a response to the cytotoxic effect of SF3. According to different
studies, exposure of breast and colon cancer cell lines to various Salvia species resulted in
decreased cell viability levels through the induction of apoptotic cell death [25,65]. These
observations are in agreement with ours not only in involving apoptotic induction as a
mode of cell death but also in revealing the involvement of major caspases representing
various modes of apoptosis. Specifically, we primarily showed the activation of the extrinsic apoptotic pathway, as evidenced by the significantly increased levels of activated
Caspase - 8 [66–69]. Moreover, Caspase - 9 activation was found to be slightly increased,
following SF3 exposure, indicating a minor involvement of the intrinsic apoptotic pathway [69–72]. In any case, we are reporting evidence of apoptotic induction primarily
through the activation of Caspases of all three levels (Caspases - 3, - 8 and - 9), while the
mode of such apoptotic induction (intrinsic versus extrinsic) remains largely speculative,
at this stage, as more elaborate studies are needed to be performed in this direction.
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4. Materials and Methods
4.1. Chemicals
Media and all cell culture related reagents were purchased from Biosera (Kansas City,
MO, USA). Sulforhodamine-B (SRB) and trichloro-acetic acid (TCA) were purchased from
Fluorochem (Glossop, UK), whereas Trisma Base, Aluminium trichloride and sodium
acetate were purchased from Sigma-Aldrich (Merk) (St. Louis, MO, USA). TBARS and
Protein Carbonyl Colorimetric Assay Kits were purchased from Cambridge Bioscience
Ltd. (Cambridge, UK). The Folin–Ciocalteu Phenolic content assay kit was purchased from
Bioquochem (Parque Tecnológico de Asturias, Llanera, Spain), whereas the Caspases - 3,
- 8 and - 9 multiplex activity assay kit was purchased from Abcam (Cambridge, UK). All
solvents were of UHPLC optima grade or better.
4.2. Plant Material and Extract Preparation
The plant material, composed of the aerial parts of S. fruticosa (SF), was collected
during full flowering from selected S. fruticosa accessions, preserved in the experimental
field of the Institute of Breeding & Plant Genetic Resources, (HAO DEMETER), Department
of Medicinal & Aromatic Plants, Thessaloniki, Greece. The extraction and generation were
carried out at the Department of Life & Health Sciences, School of Sciences & Engineering, University of Nicosia, Nicosia, Cyprus. Briefly, the air-dried SF aerial plant parts
(leaves and flowers) were gradually extracted in a Soxhlet apparatus with petroleum ether,
dichloromethane and methanol. The three obtained extracts (SF1, SF2, SF3) were concentrated to dryness under reduced pressure. The plant material was finally extracted with
water, and the extract (SF4) was evaporated under vacuum to dryness. The methanolic
extract was dissolved in boiling water, filtrated through a Whatman filter paper (pore
size; 4.0–12 µm), and the filtrate was partitioned with three solvents of increasing polarity
(diethyl ether, ethyl acetate, n-butanol). The organic layers of the above three solvents (SF5,
SF6 and SF7) were concentrated to dryness and the remaining aqueous extract (SF8) was
also collected. Stock solutions of each of the SF fractions were prepared in DMSO and kept
at 4 ◦ C, protected from light until use.
4.3. Cell Lines
The human malignant melanoma (A375) cell line was purchased from American Type
Culture Collection (ATCC—Manassas, VA, USA). The epidermoid carcinoma (A431) cell
line was purchased from Deutsche Sammlung von Microorganismen und Zellkulturen
(DSMZ—Braunschweig, Germany). HaCaT cells were kindly provided by Dr. Sharon Broby
(Dermal Toxicology & Effects Group; Centre for Radiation, Chemical and Environmental
Hazards; Public Health England, UK). All cell lines were maintained in a humidified
chamber at 37 ◦ C, under 5% CO2 atmosphere and according to the provider’s recommended
culture conditions. All cell lines were cultured for 15–20 passages before new stocks
were utilized.
4.4. Determination of Cell Viability Levels
Cell viability levels were determined by utilizing the colorimetric SRB assay. Briefly,
A375, A431, and HaCaT cells were seeded in 100 µL/well into 96-well plates and incubated
overnight prior to exposure with each of the tested SF fractions. The density of A375 cells
was 8000 and 4000 cells/well, whereas for A431 and HaCaT 10,000 and 5000 cells/well for
24 and 48 h of exposure, respectively. On the following day, cells were exposed to a range of
concentrations (0.05–1.0 mg/mL) of each SF fraction over 24 and 48 h of exposure periods.
Control cells were incubated with either complete medium only and/or DMSO (0.1%). At
the indicated time points, cells were fixed by the addition of 25 µL of 50% v/v of ice-cold
TCA solution and plates were incubated at 4 ◦ C for 1 h. Then, the cells were washed 5x
with distilled water and stained with 50 µL of 0.4% (w/v) SRB in 1% (v/v) acetic acid
for 30 min at room temperature (RT). The unbound dye was removed through 5 washes
with distilled water and the fixed/stained plates were air-dried overnight. Afterwards,
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the bound dye was solubilized by the addition of 100 µL of 10 mM Trizma base for at
least 5 min. The absorbance was measured at 570 nm using a microplate reader (LT4500,
Labtech, UK). Cell viability levels were calculated using the following Formula (1):

[sample OD 570 − blank (media)OD570
% Cell viability =
× 100
(1)
[mean control OD 570 − blank (media)OD570 ]
4.5. Determination of Total Phenolic Content (TPC)
For the determination of the Total Phenolic Content (TPC), SF fractions of equal concentrations were diluted (100×) with pre-warmed MeOH and syringe-filtered through
a 0.45 µm pore filter membrane (Ministart, Sartorius stedim Biotech, Aubagne, France).
Subsequently, TPC was quantitated by utilizing a commercial polyphenol quantification
assay kit, based on the Folin–Ciocalteu method (Bioquochem, Spain), according to the manufacture’s protocol. The absorbance was monitored at 690 nm. The TPC was determined
based on gallic acid calibration curve (linear range: 0–400 µg/mL; R2 > 0.991). The results
were expressed as µg of gallic acid equivalents (GAE)/g of dry extract.
4.6. Determination of Total Flavonoid Content (TFC)
For the determination of Total Flavonoid Content (TFC), SF fractions of equal concentrations were diluted (100×) with pre-warmed MeOH and syringe-filtered through
a 0.45 µm pore filter membrane (Ministart, Sartorius Stedim Biotech, Aubagne, France).
Briefly, 20 µL of each fraction was further diluted with 60 µL of methanol and mixed with
10 µL of aluminium trichloride (10% aqueous solution), and 10 µL of sodium acetate (0.5 M
aqueous solution). The resulting solutions were mixed by vortexing and allowed to stand
in the dark at RT for 40 min. The absorbance was monitored at 415 nm. The TFC was
determined based on both catechin (linear range: 0–100 µg/mL; R2 > 0.989) and rutin
(linear range: 0–500 µg/mL; R2 > 0.995) calibration curve. The results were expressed as
µg of catechin (CE) or µg of rutin (RE) equivalents/g of dry extract.
4.7. Determination of Malondialdehyde and Protein Carbonyl Contents
A375 cells were plated in 100 mm dishes (1.4 × 106 and 0.7 × 106 for 24 and 48 h, respectively) and cultured overnight. On the next day, cells were treated with either N-acetyl
cysteine (NAC) (2.5 mM), tert-butyl hydroperoxide (TBH) (200 µM) or SF3 (0.05 mg/mL)
for 24 and 48 h, respectively. After trypsinization, pellets were collected, re-suspended
in PBS and sonicated. For the determination of the lipid peroxidation content, the whole
suspension was further diluted with 4 mL of 4% v/v acetic acid solution containing 8%
TBA and 0.1% SDS. The final mixture was heated at 95 ◦ C for 1 h and centrifuged at
3000 rpm for 2 min. The TBARS Assay kit (Cambridge Bioscience Ltd., Cambridge, UK)
was utilized for the determination of malondialdehyde (MDA) content according to the
manufacture’s protocol. For the determination of protein carbonyl content, cells were
trypsinized and pellets were collected, re-suspended in PBS (supplemented with 1 mM
EDTA) and sonicated. The Protein Carbonyl Colorimetric Assay Kit (Cambridge Bioscience
Ltd., Cambridge, UK) was utilized according to the manufacture’s protocol.
4.8. Determination of Caspase Activity
Caspase activity was measured using the Caspases - 3, - 8 and - 9 multiplex assay
(Abcam, UK). Briefly, A375 cells were plated in 96-well plates and, on the following day,
were treated with the SF3 fraction (0.05 mg/mL). At the end of incubation, a caspase
loading solution was prepared for each substrate through the addition of 50 µL of each
caspase to 10 mL of Assay Buffer. Afterwards, 100 µL/well of caspase loading solution
were added, without removal of the cell culture medium. The cells were incubated for
1 h at RT and fluorescence was measured using a fluorescence microplate reader (Synergy
H1, Bio-Tek, VT, USA) at Eex /Eem = 535/620 nm for caspase - 3, Eex /Eem = 490/525 nm for

Plants 2021, 10, 2472

11 of 14

caspase - 8 and Eex /Eem = 370/450 nm for caspase - 9. The obtained results were expressed
as Relative Fluorescence Units (RFUs).
4.9. Statistical Analysis
Data were expressed as mean values ± standard deviation (SD) and statistical analyses
were performed by means of comparisons between control and treated cell populations.
Statistical analyses were performed by one-way ANOVA with Tukey’s test for multiple
comparisons using appropriate software (SPSS v.22). Finally, statistical significance was
established at different levels (p < 0.05, p < 0.01 and p < 0.001).
5. Conclusions
Overall, our results provide evidence for the cytotoxic potential of S. fruticosa extracts
against melanoma cells, an effect mainly attributed to its strong antioxidant activity and
activation of apoptotic cell death. Future work can focus on characterizing the underlying
molecular mechanism(s) that mediates apoptosis and/or other modes of cell death. To this
end, the activation of anoikis cell death should not be excluded, since there is scientific
evidence implicating carnosic acid (present in S. fruticosa) in the induction of anoikis
in the B16F10 murine cell line [16]. Given the great need for developing alternative
treatment options against melanoma, our results indicate that the methanolic fraction
(SF3) of S. fruticosa can act as a potential anti-melanoma agent, thereby contributing to
the development of novel pharmaceutical applications towards a more efficient clinical
management of the disease.
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